Jan 18, 2023
The pharmaceutical industry is busy pushing and churning out new "miracle" drugs that, based on the science, actually accelerate the diseases they supposedly treat. Take corticosteroids, for instance. Two recent studies show that this class of pharmaceutical, which is commonly used to treat osteoarthritis in the knees, actually contributes to the progression of the disease. "Statistical analysis showed that corticosteroid knee injections were significantly associated with the overall progression of osteoarthritis in the knee, specifically in the lateral meniscus, lateral cartilage, and medial cartilage," reported SciTech Daily. Then we have the new $56,000-per-year "miracle" Alzheimer's drug "Aduhelm" (aducanumab), which recently gained approval from the U.S. Food and Drug Administration (FDA). Aduhelm received "accelerated approval" from the FDA, which in the context of a major drug rollout is an instant red flag. T
